Intrinsic Value of S&P & Nasdaq Contact Us

Liquidia Corporation LQDA NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$50.67
+30.9%

Liquidia Corporation (LQDA) — Analyst outlook / Analyst consensus target is. Based on 7 analyst ratings, the consensus is bullish — 1 Strong Buy, 5 Buy, 1 Sell.

The consensus price target is $50.67 (low: $47.00, high: $55.00), representing an upside of 30.9% from the current price $38.71.

Analysts estimate Earnings Per Share (EPS) of $-1.54 and revenue of $0.02B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-1.66 vs est $-1.54 (missed -7.7%). 2025: actual $-0.80 vs est $-0.68 (missed -16.9%). Analyst accuracy: 89%.

LQDA Stock — 12-Month Price Forecast

$50.67
▲ +30.90% Upside
Average Price Target
Based on 7 Wall Street analysts offering 12-month price targets for Liquidia Corporation, the average price target is $50.67, with a high forecast of $55.00, and a low forecast of $47.00.
The average price target represents a +30.90% change from the last price of $38.71.
Highest Price Target
$55.00
Average Price Target
$50.67
Lowest Price Target
$47.00

LQDA Analyst Ratings

Buy
7
Ratings
6 Buy
1 Sell
Based on 7 analysts giving stock ratings to Liquidia Corporation in the past 3 months
Rating breakdown
Strong Buy
1 14%
Buy
5 71%
Sell
1 14%
86%
Buy
6 analysts
0%
Hold
0 analysts
14%
Sell
1 analysts

EPS Estimates — LQDA

89%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$1.66 vs Est –$1.54 ▼ 7.2% off
2025 Actual –$0.80 vs Est –$0.68 ▼ 14.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — LQDA

92%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.014B vs Est $0.016B ▼ 13.5% off
2025 Actual $0.158B vs Est $0.154B ▲ 2.8% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message